JPRN-UMIN000038508
Not yet recruiting
未知
A prospective observational study of biomarkers for Second-line FOLFIRI plus Aflibercept treatment in patients with metastatic colorectal cancer comparing to FOLFIRI plus beVacizumab: an Exploratory biomarker study. - SAVE Trial
Conditionscolorectal cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- colorectal cancer
- Sponsor
- Kyoto University Hospital
- Enrollment
- 70
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Having an infection which needs systemic treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective observation study of biomarkers to predict patterns of recurrence after curative surgery for gastric cancerGastric cancerJPRN-UMIN000030111agoya University Graduate School of Medicine300
Completed
Not Applicable
A prospective observation study of biomarkers to detect or predict peritoneal metastasis of gastric cancerGastric cancerJPRN-UMIN000030112agoya University Graduate School of Medicine350
Recruiting
Not Applicable
Prospective observational study of biomarkers to predict efficacy after Nivolumab in patients with previously treated advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000020823Gunma University30
Unknown
Not Applicable
Prospective observational study of biomarkers to predict efficacy after Pembrolizumab in patients with PD-L1 positive advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000026793Gunma University50
Recruiting
Not Applicable
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)JPRN-UMIN000046198agasaki University125